PATENT CLAIM ANALYSIS

Application Number: 16378361
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["424", "718000"]

Abstract:
The invention relates methods of reducing the risk or preventing the occurrence of an adverse event (AE) or a serious adverse event (SAE) associated with a medical treatment comprising inhalation of nitric oxide.

Claim (Index 47):
The method of  claim 33 , wherein the pre-existing left ventricular dysfunction of (b) is attributable to congenital heart disease.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 100.0
- Lexical Diversity: 1.31034
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12821041', '14454373', '14451057', '12821020', '13651660']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8442700396182038
- 35 USC 102 Novelty (BERT): 0.6387781042109069
- Combined Prediction Score: 0.8237208460774741
- Mean Citation Score: 668.4344120000002
- Max Citation Score: 676.1624
- Similarity Product: 551.4667135643006

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test